tranexamic acid has been researched along with Sickle Cell Trait in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Sickle Cell Trait: The condition of being heterozygous for hemoglobin S.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cochrane, AM | 1 |
Barton, KT | 1 |
Turner, MN | 1 |
Hulbert, ML | 1 |
1 other study available for tranexamic acid and Sickle Cell Trait
Article | Year |
---|---|
Tranexamic acid for management of gross hematuria due to renal papillary necrosis in sickle cell disease.
Topics: Anemia, Sickle Cell; Hematuria; Humans; Kidney Papillary Necrosis; Necrosis; Sickle Cell Trait; Tran | 2023 |